Postpartum period: a risk factor for neuroleptic malignant syndrome
Affiliations
Affiliations
- Department of Psychiatry, Faculty of Medicine, Kuwait University, Safat.
Abstract
Neuroleptic malignant syndrome (NMS) occurred in four postpartum patients treated with various psychotropic medications including depot-neuroleptics over a 5-year period. All four patients had the onset of NMS in the first few weeks of the postpartum period. Whether or not there is an increased risk for the development of NMS in the puerperium period is discussed.
Similar articles
[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S, Kornreich C, Choubani Z, Gourevitch R.Encephale. 2008 Dec;34(6):618-24. doi: 10.1016/j.encep.2007.11.007. Epub 2008 Apr 2.PMID: 19081460 Review. French.
[A study of neuroleptic malignant syndrome in the presenium and senium].
Suzuki I, Honma H, Watanabe N, Matsubara S, Koyama T.Seishin Shinkeigaku Zasshi. 1998;100(6):387-97.PMID: 9745353 Japanese.
Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.
Bottlender R, Jäger M, Hofschuster E, Dobmeier P, Möller HJ.Pharmacopsychiatry. 2002 May;35(3):119-21. doi: 10.1055/s-2002-31518.PMID: 12107858
Olanzapine induced neuroleptic malignant syndrome--a case review.
Kogoj A, Velikonja I.Hum Psychopharmacol. 2003 Jun;18(4):301-9. doi: 10.1002/hup.483.PMID: 12766935 Review.
Recurrence of neuroleptic malignant syndrome.
Susman VL, Addonizio G.J Nerv Ment Dis. 1988 Apr;176(4):234-41. doi: 10.1097/00005053-198804000-00007.PMID: 2895164 Review.
Cited by
A case of neuroleptic malignant syndrome induced by olanzapine in postpartum period.
Ustündağ M, Orak M, Güloğlu C, Sayhan MB, Taş M.Indian J Psychiatry. 2007 Oct;49(4):287-9. doi: 10.4103/0019-5545.37671.PMID: 20680143 Free PMC article.